- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01980537
Stereotaxis and Chronic Total Occlusion
November 4, 2013 updated by: Univ. Prof. Dr. Thomas Neunteufl, Medical University of Vienna
Wire-crossing of a chronic total coronary occlusion (CTO) is time-consuming and limited by the amount of contrast agent and time of radiation exposure.
Magnetic wire navigation might accelerate wire-crossing by maintaining a coaxial vessel orientation.
This study compares magnetic with conventional wire navigation for recanalization of CTOs.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- symptomatic
- preserved wall motion or viable myocardium
- chronic total occlusion
Exclusion Criteria:
- chronic renal failure
- prior allergic reactions against contrast agent
- hyperthyreosis
- claustrophobia
- pregnancy
- contraindications to aspirin or clopidogrel
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stereotaxis
Magnetic wire navigation
|
|
|
Active Comparator: Conventional
Conventional wire navigation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
level of contrast medium
Time Frame: 8 hours
|
8 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2008
Primary Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
October 24, 2013
First Submitted That Met QC Criteria
November 4, 2013
First Posted (Estimate)
November 11, 2013
Study Record Updates
Last Update Posted (Estimate)
November 11, 2013
Last Update Submitted That Met QC Criteria
November 4, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Stereotaxis and CTO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.